J.-A. Sperl-Hillen

Effect of Intensive Glycemic Lowering on Health-Related Quality of Life in Type 2 Diabetes

Roger. T. Anderson, R. Cuddihy, A. Sood, 2011, Diabetes Care.

Reversibility of Fenofibrate Therapy–Induced Renal Function Impairment in ACCORD Type 2 Diabetic Participants

T. Craven, D. Bonds, J. Buse, 2012, Diabetes Care.

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience

P. O’Connor, T. Craven, D. Bonds, 2012, Diabetologia.